We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

A tumor-informed SV-based ctDNA test anticipates breast cancer relapse by up to 4 years, enabling MRD-guided follow-up. More...
27 May 2026
Image: MCD tests are designed to detect multiple cancers from a single blood sample, but the statements note that evaluating these assays is far more complex than assessing single-cancer tests (image credit: Adobe Stock)

Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

New position statements outline evidence standards for assessing emerging multi-cancer detection tests.

 
 
More...
27 May 2026
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

New findings show biomarkers in extracellular vesicles can help diagnose childhood epilepsy. More...
27 May 2026
Image: Canhelp‑UCa is a CE‑marked IVD molecular assay developed for the noninvasive detection and recurrence monitoring of urothelial carcinoma of the bladder and upper urinary tract (Photo courtesy of Canhelp Genomics)

New Distribution Agreement Expands Access to CE-Marked Precision Oncology Assays

Eurobio Scientific has signed agreement with Canhelp Genomics to broaden European distribution of the Canhelp‑UCa and Canhelp‑Origin assays. More...
27 May 2026
Image: Research team leader Professor Klaus Gerwert and study lead author Dr. Grischa Gerwert in a betaSENSE laboratory (Photo courtesy of Dennis Yenmez/Stadt Bochum)

Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s

A novel immuno-infrared blood test detects misfolded protein biomarkers for Alzheimer’s and Parkinson’s disease. More...
27 May 2026
Image: The study represents a major pediatric oncology breakthrough, offering a potential roadmap for personalizing treatment in difficult-to-treat childhood cancers (image credit: Adobe Stock)

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers

A measure of tumor chromosome abnormalities predicts benefit from irinotecan plus a PARP inhibitor in relapsed pediatric cancers. More...
27 May 2026
Image: Artera’s multi-modal AI platform analyzes digital pathology and clinical data to support personalized cancer management (photo courtesy of Artera)

Artera to Highlight AI-Based Cancer Risk Stratification at ASCO 2026

Artera’s multimodal artificial intelligence (MMAI) platform will be featured in multiple presentations at the ASCO 2026 Annual Meeting More...
27 May 2026
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Copyright © 2000-2026 Globetech Media. All rights reserved.